“Exploring Therapeutic Strategies for cblC Disease: Italy-Turkey Collaboration” (EXIT), a research proposal, has been officially accepted by TÜBİTAK. This collaboration aims to combine the expertise of Turkish scientists from İzmir Biomedicine and Genome Center, led by Prof. Dr. Esra Erdal Bağrıyanık, with the Biophysics Institute (IBF) of the Italian National Research Council (CNR), to address the challenges posed by the rare genetic disorder cblC disease.
Commencing in November 2024 and spanning two years, this initiative highlights the power of international cooperation in scientific advancement. The Turkish team will focus on creating disease-specific cellular models and evaluating potential therapies, including brain and liver organoids derived from iPSCs.
Dr. Silvia Vilasi’s team from the Biophysics Institute at CNR will lead efforts to identify and characterize small molecules capable of restoring protein function or enabling the interpretation of genetic mutations.
The project promises significant advancements, from identifying potential drug candidates to understanding mechanisms of rare diseases.
13 January 2025
Organo-ID was hosted on Ekotürk TV, where we conducted an in-depth interview about our innovative work. During the interview, we discussed organoid technologies, specifically our research on breast, pancreatic, and colorectal cancer organoids, and how these studies contribute to personalized medicine. Additionally, we introduced our Organo-ChemoTest Report product, which helps us determine which drugs are most effective by analyzing cancerous tissues from patients.
During the interview, we also gave a tour of our laboratory and shared insights into our experimental processes. We had an enjoyable conversation with the Ekotürk TV team, and had the opportunity to showcase the potential of organoid technology and our Chemotest Report product in cancer treatment to a broader audience.
This interview not only allowed us to highlight the power of organoid technology and the future of personalized medicine but also reinforced Organo-ID’s leadership in this field.
7 October 2024
We are proud to announce our new R&D project entitled ‘Pilot Study on Possible Uses of the Patient-Derived Breast Cancer Organoid Model in Personalized Medicine Applications’, supported by the TÜBİTAK TEYDEB 1507 program. As ORGANO-ID, we would like to thank TÜBİTAK for supporting us in the validation of the PDCO test platform that we plan to implement in the treatment decision of breast cancer patients.
27 January 2023
Our company gained useful knowledge about strategic management during the trainings it received as part of the Dokuz Eylül Health Industry Export and International Competitiveness Development Project. Furthermore, ORGANO-ID expanded its professional network.
5-6 December 2022
Izmir Beyond Hotel
Prof. Dr. Esra Erdal, at the TRANSPLANTATION’22 Congress organized by the Turkish Organ Transplantation Organizations Coordination Association, mentioned that organoids, the technology currently used and developed by our company, can be used as an alternative to organ transplantation.
13-15 October 2022
Limak Cyprus Deluxe Hotel, Kıbrıs, Turkiye
Clinician collagues were very interested to the ORGANO-ID PDCOs to choose better treatment option for their patients.
28 September – 01 October 2022
Istanbul Congress Center, Turkiye
ORGANO-ID has successfully presented high-tech solutions for personalized cancer treatment and Pre-clinical Disease Modeling at TEKNOFEST in Samsun. TEKNOFEST Aerospace and Technology Festival is organized with the partnership of Turkey’s most important institutions and organizations whose main goals are realizing the National Technology Initiative and transforming Turkey into a technology developing society.
30th August – 4th September
Samsun Carsamba Airport, Turkiye
ORGANO-ID researchers presented a pilot study representing the efficiency of the patient derived cancer organoid model for personalized drug response prediction and discuss the data with the colleagues having expertise in the field.
9-12 June 2022
Acıbadem University, Istanbul, Turkiye